CJC-1295 DAC Nasal Spray
CJC-1295 DAC Nasal Spray contains CJC-1295 DAC, a synthetic modified growth hormone-releasing hormone (GHRH) analogue incorporating a Drug Affinity Complex (DAC) modification and investigated in experimental research, and is available from Direct SARMs in 15 ml and 30 ml sizes.
Sale!
98.7% purityBatch COA includedStore 2–8°C
Price range: $40.25 through $74.25
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought CJC-1295 DAC Nasal Spray also bought
CJC-1295 DAC Nasal Spray
CJC-1295 DAC is a synthetic analogue of human growth hormone-releasing hormone (GHRH), based on the biologically active GHRH(1–29) sequence and incorporating several amino-acid substitutions together with a Drug Affinity Complex (DAC) modification. Published scientific studies have investigated CJC-1295 DAC in relation to GHRH receptor-mediated signalling and the growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis. These findings relate to the specific experimental conditions and administration routes investigated and should not be interpreted as establishing effects associated with the nasal spray format.
Direct SARMs supplies CJC-1295 DAC as a pre-mixed aqueous nasal spray format for laboratory and analytical research. The 15 ml format contains 2 mg of CJC-1295 DAC, while the 30 ml format contains 4 mg. The nasal spray designation describes the physical presentation of the research material and does not establish intranasal bioavailability, biological activity, safety or suitability for administration.
CJC-1295 DAC Nasal Spray is supplied solely as a laboratory research material and is not intended for human or animal consumption or administration, or for diagnostic, therapeutic, clinical or veterinary use.
Benefits of the nasal spray format
1
The dispensing is pre-measured. Each time the spray mechanism is actuated, it releases a constant volume, which allows for repeatable dispensing when carrying out research procedures.
2
Convenient format. Compact spray bottles are straightforward to store, handle, and transport within an appropriate research environment.
3
Ready to use. Unlike lyophilized peptides, which are provided in vials, nasal spray formulations are in liquid form and do not need to be reconstituted before being handled in the laboratory.
4
Protected storage. The bottle protects the formulation by preventing unnecessary handling and exposure to the environment between research procedures.
5
Simple dispensing. The product can be dispensed easily. With an integrated spraying mechanism, it is not necessary to draw the liquid from a vial, offering a simple way to dispense the formulation during research.
Visit the CJC-1295 DAC Research Hub ▸
CJC-1295 DAC is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy CJC-1295 DAC Nasal Spray Bulgaria from Direct SARMS.
Additional information
| Size(s) | 15ml and 30ml |
| Amount Per Nasal | 15ml = 2mg | 30ml = 4mg |
| Purity | 98.7% |
| Molecular Formula | C159H258N46O45 |
| Molecular Weight | 3647.65 g/mol |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Physical Form | Pre-mixed aqueous solution |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this CJC-1295 DAC compound?
CJC-1295 DAC Nasal Spray is supplied as a pre-mixed aqueous solution, providing the peptide in liquid form rather than as a dry or lyophilised research material.
Direct SARMs supplies CJC-1295 DAC Nasal Spray in 15 ml and 30 ml formats. The 15 ml format contains 2 mg of CJC-1295 DAC, while the 30 ml format contains 4 mg.
DAC is an abbreviation for Drug Affinity Complex. The CJC-1295 DAC compound has a modification in the form of maleimidopropionic acid which is linked in such a way as to allow a covalent interaction with albumin. This characteristic is what sets the DAC version apart from other GHRH analogues which do not have this modification.
No. CJC-1295 DAC and compounds marketed as CJC-1295 No DAC should not be treated as interchangeable molecular entities. The FDA has specifically highlighted inconsistent naming among CJC-1295-related substances and the potential for this to create structural and analytical confusion.
Certificate of Analysis
| Identity | CJC-1295 DAC | CONFORMS |
| Purity (HPLC) | 98.7% | CONFORMS |
| Mass (LC-MS) | 3647.65 g/mol | CONFORMS |
| Appearance | Pre-mixed aqueous solution | CONFORMS |
